This study presents outcomes of patients treated with ranibizumab for branch and central retinal vein occlusion (BRVO and CRVO). Source: AAO
This week, Chinese scientists unveil color-changing contacts that respond to ocular fluctuations, Alcon’s allergy eye drops are now available over the counter and a blue laser attack nearly blinds a highway patrol pilot. Source: AAO
In this extension trial, investigators compared the effect of continued or discontinued use of omega-3 fatty acid supplements among participants of the DREAM study. Source: AAO
This literature review compares the efficacy of 3 of the most commonly employed endophthalmitis prophylaxis antibiotics: cefuroxime, vancomycin and moxifloxacin. Source: AAO
The authors described a case of a 6-year-old girl who developed bilateral optic neuritis following inactivated influenza vaccination. Source: AAO
In a cross-sectional, population-based survey, the authors determined the association between retinal thickness and cognitive function. Source: AAO
This week, an artificial intelligence algorithm for ROP gains breakthrough designation, a gene therapy for wet AMD shows promise and novel dexamethasone eye drops effectively treat DME. Source: AAO
This a randomized, double-masked, placebo-controlled, phase 3 multicenter trial evaluating the insulin-like growth factor I receptor (IGF-IR) inhibitor teprotumumab for treating thyroid eye disease. Source: AAO
This paper describes OCT-guided localization and photocoagulation of invisible retinoblastoma tumors in pediatric patients. Source: AAO
This prospective study investigated 1-year outcomes of various corneal crosslinking (CXL) techniques for treating progressive keratoconus. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »